Published in J Immunol on April 01, 2009
Clonotypically similar hybrid αβ T cell receptors can exhibit markedly different surface expression, antigen specificity and cross-reactivity. Clin Exp Immunol (2015) 1.40
Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 1.16
Engineering T cells for cancer: our synthetic future. Immunol Rev (2014) 0.88
A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. J Immunol (2011) 0.86
Rational design of T cell receptors with enhanced sensitivity for antigen. PLoS One (2011) 0.83
T cell engineering as therapy for cancer and HIV: our synthetic future. Philos Trans R Soc Lond B Biol Sci (2015) 0.80
How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer. Front Immunol (2012) 0.79
Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy. Arch Immunol Ther Exp (Warsz) (2010) 0.78
Preferential Use of Public TCR during Autoimmune Encephalomyelitis. J Immunol (2016) 0.77
CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors. J Autoimmun (2015) 0.77
New approaches for the immunotherapy of acute myeloid leukemia. Discov Med (2015) 0.75
Cancer regression in patients after transfer of genetically engineered lymphocytes. Science (2006) 16.96
Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol (2006) 7.76
How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 7.57
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science (1992) 3.39
How the T cell repertoire becomes peptide and MHC specific. Cell (2005) 3.39
The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23
Generation of T-cell receptor retrogenic mice. Nat Protoc (2006) 3.05
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity (2003) 3.04
Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol (2005) 2.97
Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat Methods (2006) 2.87
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions. J Immunol (2008) 2.54
HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (1992) 2.54
From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell (1999) 2.52
DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J Immunol (2000) 2.50
Structural basis of T cell recognition. Annu Rev Immunol (1999) 2.45
Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules. Immunity (2008) 2.31
TCRs with high affinity for foreign pMHC show self-reactivity. Nat Immunol (2002) 2.12
Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity (2005) 2.03
In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci U S A (2000) 1.92
High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol (2007) 1.85
Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition. Immunity (1998) 1.80
What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol (2007) 1.64
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood (2006) 1.60
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest (2003) 1.59
Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc Natl Acad Sci U S A (2005) 1.46
Adoptive cell transfer therapy. Semin Oncol (2007) 1.44
Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol Rev (1997) 1.33
Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells. Proc Natl Acad Sci U S A (2002) 1.22
Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity. J Immunol (2008) 1.17
The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy. J Immunol (2006) 1.08
Display, engineering, and applications of antigen-specific T cell receptors. Biomol Eng (2007) 1.08
Exploiting T cell receptor genes for cancer immunotherapy. Clin Exp Immunol (2005) 1.01
Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. Eur J Immunol (2006) 0.98
Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide. Eur J Immunol (2004) 0.90
Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor. J Immunol (2008) 0.86
Binding motifs predict major histocompatibility complex class II-restricted epitopes in the Sendai virus M protein. J Virol (1995) 0.86
Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes. Int Immunol (2006) 0.83
Redirecting T cell specificity by TCR gene transfer. Nat Immunol (2001) 0.78
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med (2011) 2.97
Microvascular lifeboats: a stepwise approach to intraoperative venous congestion in DIEP flap breast reconstruction. Plast Reconstr Surg (2014) 2.80
Functional genomic analysis of the response of HIV-1-infected lymphatic tissue to antiretroviral therapy. J Infect Dis (2004) 2.68
Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. Neuron (2010) 2.20
Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity (2013) 2.08
A surface on the androgen receptor that allosterically regulates coactivator binding. Proc Natl Acad Sci U S A (2007) 1.97
A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol (2007) 1.91
Identification of errors introduced during high throughput sequencing of the T cell receptor repertoire. BMC Genomics (2011) 1.87
Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity (2004) 1.77
Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance. J Immunol (2008) 1.71
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. J Biol Chem (2004) 1.66
Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia. Dev Med Child Neurol (2013) 1.58
Effects of micronutrients on growth of children under 5 y of age: meta-analyses of single and multiple nutrient interventions. Am J Clin Nutr (2008) 1.47
A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J Immunol (2007) 1.47
Induction of B-cell immune tolerance by antigen-modified cytotoxic T lymphocytes. Transplantation (2010) 1.43
Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes. Nat Biotechnol (2002) 1.42
Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators. J Biol Chem (2005) 1.32
Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling. Cancer Cell (2006) 1.28
Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS One (2012) 1.28
Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol (2005) 1.21
Differential SERM effects on corepressor binding dictate ERalpha activity in vivo. J Biol Chem (2002) 1.20
Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity. J Immunol (2008) 1.17
IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc Natl Acad Sci U S A (2005) 1.16
Early complications in children with acute lymphoblastic leukemia presenting with hyperleukocytosis. Pediatr Blood Cancer (2005) 1.14
TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest (2011) 1.13
Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor. Mol Endocrinol (2007) 1.10
Rearrangements in thyroid hormone receptor charge clusters that stabilize bound 3,5',5-triiodo-L-thyronine and inhibit homodimer formation. J Biol Chem (2005) 1.10
S-palmitoylation of gamma-secretase subunits nicastrin and APH-1. J Biol Chem (2008) 1.09
Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease. J Immunol (2004) 1.09
A high-throughput screening method to identify small molecule inhibitors of thyroid hormone receptor coactivator binding. Sci STKE (2006) 1.08
Thyroid hormone response element organization dictates the composition of active receptor. J Biol Chem (2007) 1.07
Structural basis of coactivation of liver receptor homolog-1 by β-catenin. Proc Natl Acad Sci U S A (2011) 1.06
Gaining ligand selectivity in thyroid hormone receptors via entropy. Proc Natl Acad Sci U S A (2009) 1.05
In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol (2002) 1.05
Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect (2003) 1.05
Growth, interaction, and positioning of microtubule asters in extremely large vertebrate embryo cells. Cytoskeleton (Hoboken) (2012) 1.02
Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol (2005) 1.02
Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Blood (2004) 0.99
T cell receptor CDR3 sequence but not recognition characteristics distinguish autoreactive effector and Foxp3(+) regulatory T cells. Immunity (2009) 0.99
Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function. Blood (2003) 0.98
Soluble γ-secretase modulators selectively inhibit the production of the 42-amino acid amyloid β peptide variant and augment the production of multiple carboxy-truncated amyloid β species. Biochemistry (2014) 0.98
Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp Mol Pathol (2005) 0.97
Discrete TCR repertoires and CDR3 features distinguish effector and Foxp3+ regulatory T lymphocytes in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis. J Immunol (2010) 0.96
SureSmile: a report of clinical findings. J Clin Orthod (2005) 0.95
4-Pyridylanilinothiazoles that selectively target von Hippel-Lindau deficient renal cell carcinoma cells by inducing autophagic cell death. J Med Chem (2010) 0.94
ERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminus. Nucl Recept (2003) 0.94
Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer (2008) 0.93
Neuronal HIF-1 alpha protein and VEGFR-2 immunoreactivity in functionally related motor areas following a focal M1 infarct. J Cereb Blood Flow Metab (2007) 0.93
Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control (2012) 0.93
β-cell metabolic alterations under chronic nutrient overload in rat and human islets. Islets (2012) 0.92
Self-organization of stabilized microtubules by both spindle and midzone mechanisms in Xenopus egg cytosol. Mol Biol Cell (2013) 0.92
Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4+ T cells. J Immunol (2004) 0.91
IL-10-dependent suppression of experimental allergic encephalomyelitis by Th2-differentiated, anti-TCR redirected T lymphocytes. J Immunol (2005) 0.91
Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes. J Immunol (2005) 0.91
A case of hemoglobin SC disease with cold agglutinin-induced hemolysis. Am J Hematol (2005) 0.90
Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury. J Neurotrauma (2014) 0.89
Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J Immunol (2003) 0.89
T cell reactivity during infectious mononucleosis and persistent gammaherpesvirus infection in mice. J Immunol (2004) 0.88
A conserved lysine in the estrogen receptor DNA binding domain regulates ligand activation profiles at AP-1 sites, possibly by controlling interactions with a modulating repressor. Nucl Recept (2004) 0.88
Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines. Mol Cell Endocrinol (2008) 0.87
Stop the drama Downunder: a social marketing campaign increases HIV/sexually transmitted infection knowledge and testing in Australian gay men. Sex Transm Dis (2012) 0.87
Allosteric conversation in the androgen receptor ligand-binding domain surfaces. Mol Endocrinol (2012) 0.87
Human papillomavirus and abnormal Pap test results in Vietnamese-American women: a pilot case-control study. J Low Genit Tract Dis (2004) 0.87
Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor. J Immunol (2008) 0.86
Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction. J Autoimmun (2007) 0.86
A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. J Immunol (2011) 0.86
Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditions. Cell Immunol (2012) 0.86
Mapping of two antigenic domains on the NS3 protein of the pestivirus bovine viral diarrhea virus. Vet Microbiol (2005) 0.86
Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Arthritis Rheum (2003) 0.85
The T cell response to IL-10 alters cellular dynamics and paradoxically promotes central nervous system autoimmunity. J Immunol (2012) 0.84
Laparoscopic distal pancreatic resection. Am Surg (2005) 0.83
Dependence of stress resistance on a spore coat heteropolysaccharide in Dictyostelium. Eukaryot Cell (2008) 0.83
Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes. Int Immunol (2006) 0.83
Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation. Cancer Epidemiol (2013) 0.83
Risk factors associated with hemoglobin levels and nutritional status among Brazilian children attending daycare centers in Sao Paulo City, Brazil. Arch Latinoam Nutr (2010) 0.83
Rational design of T cell receptors with enhanced sensitivity for antigen. PLoS One (2011) 0.83
Immunophototherapy using PDT combined with rapid intratumoral dendritic cell injection. Photochem Photobiol (2008) 0.82
Altered differentiation, diminished pathogenicity, and regulatory activity of myelin-specific T cells expressing an enhanced affinity TCR. J Immunol (2011) 0.82
Activin a release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury. J Neurotrauma (2006) 0.82
Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis. Eur J Immunol (2013) 0.81
Interrelationship between growth and development in low and middle income countries. Nestle Nutr Workshop Ser Pediatr Program (2010) 0.80
A developmental systems approach to executive function. Adv Child Dev Behav (2013) 0.79
Mid-upper-arm and calf circumferences are useful predictors of underweight in women of reproductive age in northern Vietnam. Food Nutr Bull (2014) 0.79
Stress in pregnancy activates neurosteroid production in the fetal brain. Neuroendocrinology (2006) 0.79
Battery life following pallidal deep brain stimulation (DBS) in children and young people with severe primary and secondary dystonia. Childs Nerv Syst (2012) 0.79
Transfusion-associated immune modulation: a reason to TRIM platelet transfusions? Transfusion (2008) 0.79
Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy. Arch Immunol Ther Exp (Warsz) (2010) 0.78